Company Active LTD

Company profile

Metrion Biosciences Ltd

Metrion Biosciences Metrion Biosciences

Metrion Biosciences is a specialist ion channel contract research organisation providing drug discovery services to pharmaceutical and bioscience customers

CRN
09669815
Founded
2015
Age
11

Overview

Legal name
METRION BIOSCIENCES LTD
Region
East of England
Registered address
FIRST FLOOR, BUILDING 2 GRANTA CENTRE, GRANTA PARK
GREAT ABINGTON
CAMBRIDGE
UNITED KINGDOM
CB21 6AL
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

Metrion Biosciences Ltd
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

16 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

02 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

21 Feb
2025

Capital Allotment Shares

Capital

SH01 | Transaction MzQ1NjAwMzE4M2FkaXF6a2N4

Published 21 Feb 2025 04:27

03 Jul
2015

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2015
Funded years
2015, 2018, 2019, 2020
Age at first award
0 years

Projects

2020 Small Business Research Initiative Lead participant

Approaching Carbon-zero cardiac safety testing in drug development: Green Biology

1 Oct 2020 to 31 Dec 2020

Awarded
£59,954
Total cost £59,954

Metrion Biosciences ("Metrion") is a UK-based contract research organisation (CRO) specialising in a class of human proteins called ion channels. The company was formed in September 2015 and provides early stage pharmaceutical research and safety assessment services to the worldwide pharmaceutical and life sciences industry. Metrion combines intellectual ...

2020 Feasibility Studies Lead participant

Continuity: Recommissioning of electrophysiology laboratories for R&D

1 Jun 2020 to 30 Nov 2020

Awarded
£30,956
Total cost £30,956

no public description

2019 Feasibility Studies Lead participant

Development of a novel human primary T-cell assay for translation of preclinical discovery to patients with autoimmune diseases

1 Jul 2019 to 31 Oct 2020

Awarded
£69,989
Total cost £99,984

"Metrion Biosciences recently (January 2018) established a specialist ion channel drug discovery subsidiary, Metrion Pharma Ltd (Metrion). The Company is wholly owned by Metrion Biosciences. Ion channels are proteins located in cell membranes that are responsible for controlling nerve impulses, muscle contractions, beating of the heart, function of the se...

2018 Feasibility Studies Lead participant

Late lead optimisation of orally available potassium channel inhibitors for the treatment of psoriasis

1 Sep 2018 to 29 Feb 2020

Awarded
£445,938
Total cost £637,055

"-- Metrion Bioscience Ltd (Metrion) is an ion channel specialist contract research organisation and has recently begun building its drug discovery and development capability. The company is based at Granta Park, Cambridge, with a core expertise in ion channel drug discovery and neuroscience. Metrion's R&D is focused on designing and discovering molecules...

2018 Feasibility Studies Lead participant

Kv1.3 inhibitors as innovative disease modifying drugs for Progressive Multiple Sclerosis

1 Feb 2018 to 31 Jan 2019

Awarded
£139,989
Total cost £199,984

"Metrion Bioscience Ltd (Metrion) is a specialist ion channel contract research organisation (CRO) and drug discovery company. Ion channels are proteins located in cell membranes that are responsible for controlling nerve impulses, muscle contractions, beating of the heart, function of the senses and the physiological activity of many other cells and tiss...

2015 EU-Funded Lead participant

Eurostars XTN_NAN_LDN-CardioPredict

1 Jun 2015 to 31 Aug 2017

Awarded
£289,426
Total cost £482,376

Awaiting Public Project Summary

Product types

EU-Funded Feasibility Studies Small Business Research Initiative